Kim Kyu-won
Born1952 (age 71–72)
Daegu, South Korea
NationalitySouth Korean
Alma materUniversity of Minnesota, Minneapolis, United States
Known forAngiogenesis Vascular Biology, Blood-Brain Barrier
AwardsDistinguished Science Award of the Month, Korea Science and Engineering Foundation (2003)
Top Scientist and Technologist Award of Korea (2003)[1]
The Role Model Scientists, Korea Science Foundation (2005)
Ho-Am Prize in medicine, Ho-Am Foundation (2005)
Chungsan Award, Korean Society for Biochemistry and Molecular Biology (2012)
Scientific career
FieldsBioscience
InstitutionsSeoul National University
Doctoral advisorRobert J. Roon
Korean name
Hangul
Revised RomanizationGim Gyu-won
McCune–ReischauerKim Kyuwŏn

Kim Kyu-won is a South Korean biologist.

Education

Kim graduated from Seoul National University in 1976, and the Masters programme at the Korea Advanced Institute of Science and Technology in 1978, before going on to study a Ph.D. in Biochemistry at the University of Minnesota in Minneapolis, United States, concluding in 1985.

Work

Kim's post-doctorate career began as a Postdoctoral Fellow at the Department of Cancer Genetics, Dana–Farber Cancer Institute, Harvard Medical School between 1985 and 1987.

  • Academic Appointment[2][3][4][5][6][7][8]
    • Assistant Professor, Associate Professor, Professor, Department of Molecular Biology, Pusan National University, Korea (1987 - 2000)
    • Director, Research Institute of Genetic Engineering, Pusan National University, Korea (1994 - 1998)
    • Professor, College of Pharmacy, Seoul National University, Korea (2000)
    • President, The Korean Society for Vascular Biology (2001 - 2003)
    • Full member, The Korean Academy of Science and Technology (2001)
    • Vice-chairman, The Korean Cancer Association (2011 - 2012)

Technical reports and conference/event proceedings

  • 8th Cerebral Vascular Biology International Conference, Invited lecturer, Japan (2008)
  • 12th International Symposium Signaling at Blood Brain and Blood Retinal Barrier, Invited lecturer, United Kingdom (2009)
  • The Second Pacific Symposium on Vascular Biology, Invited speaker, South Korea (2011)
  • 70th Annual Meeting of the Japanese Cancer Association (JCA2011), Chairman/ Organizer, Japan (2011)
  • The XXVth International Symposium on Cerebral Blood Flow, Metabolism, and Function, Invited lecturer, Spain (2011)
  • Seoul Brain Barrier Symposium, Organizer, South Korea (2012)

References

  1. ↑ 김상일 (16 April 2003). "김규원 교수 '최고과학기술인상' 수상". 의학신문 (in Korean). Retrieved 16 November 2023.
  2. ↑ Myoung Sook Kim; Ho Jeong Kwon; You Mie Lee; Jin Hyen Baek; Jae-Eun Jang; Sae-Won Lee; Eun-Joung Moon; Hae-Sun Kim; Seok-Ki Lee; Hae Young Chung; Chul Woo Kim; Kyu-Won Kim (2001). "Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes". Nature Medicine. 7 (3): 437–443. doi:10.1038/86507. PMID 11283670. S2CID 1892708.
  3. ↑ Joo-Won Jeong; Moon-Kyoung Bae; Mee-Young Ahn; Se-Hee Kim; Tae-Kwon Sohn; Myung-Ho Bae; Mi-Ae Yoo; Eun Joo Song; Kong-Joo Lee; Kyu-Won Kim (2002). "Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation". Cell. 111 (5): 709–720. doi:10.1016/S0092-8674(02)01085-1. PMID 12464182.
  4. ↑ Sae-Won Lee; Woo Jean Kim; Yoon Kyung Choi; Hyun Seok Song; Myung Jin Son; Irwin H. Gelman; Yung-Jin Kim; Kyu-Won Kim (2003). "SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier". Nature Medicine. 9 (7): 900–906. doi:10.1038/nm889. PMID 12808449. S2CID 25232544.
  5. ↑ Yoon Kyung Choi; Jeong Hun Kim; Woo Jean Kim; Hae Young Lee; Jeong Ae Park; Sae-Won Lee; Dae-Kwan Yoon; Hyun Ho Kim; Hum Chung; Young Suk Yu; Kyu-Won Kim (2007). "AKAP12 regulates human blood-retinal barrier formation by downregulation of HIF-1a". Journal of Neuroscience. 27 (16): 4472–4481. doi:10.1523/jneurosci.5368-06.2007. PMC 6672308. PMID 17442832.
  6. ↑ Hyo-Jong Lee; Bum Ju Ahn; Min Wook Shin; Joo-Won Jeong; Jeong Hun Kim; Kyu-Won Kim (2009). "Ninjurin1 mediates macrophage-induced programmed cell death during early ocular development". Cell Death and Differentiation. 16 (10): 1395–407. doi:10.1038/cdd.2009.78. PMID 19557008.
  7. ↑ Mi-Ni Lee; Shi-Nai Lee; Se-Hee Kim; Bora Kim; Bo-Kyung Jung; Ji Hae Seo; Ji-Hyeon Park; Jae-Hoon Choi; Sun Hee Yim; Mi-Ran Lee; Jong-Gil Park; Ji-Young Yoo; Jeong Hun Kim; Seung-Taek Lee; Hwan-Mook Kim; Sandra Ryeom; Kyu-Won Kim; Goo Taeg Oh (2010). "Roles of arrest-defective protein 1(225) and hypoxia-inducible factor 1 alpha in tumor growth and metastasis". J Natl Cancer Inst. 102 (6): 426–442. doi:10.1093/jnci/djq026. PMC 2841038. PMID 20194889.
  8. ↑ Hoetzenecker W, Echtenacher B, Guenova E, Hoetzenecker K, Woelbing F, Brück J, Teske A, Valtcheva N, Fuchs K, Kneilling M, Park JH, Kim KH, Kim KW, Hoffmann P, Krenn C, Hai T, Ghoreschi K, Biedermann T, Röcken M (2011). "ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression". Nat. Med. 18 (1): 128–34. doi:10.1038/nm.2557. PMC 3555699. PMID 22179317.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.